Potiandi Serge Diagbouga

Potiandi Serge Diagbouga

Auto-generated profile, based on publicly available information

Potiandi Serge Diagbouga

Unité de Recherche sur Les Maladies à potentiel épidémique, Maladies émergentes et Zoonoses, Département Biomédical et Santé Publique Institut de Recherche en Sciences de La Santé (IRSS/CNRST) Ouagadougou Burkina Faso

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SRSolenne Robert
Solenne Robert
PDPotiandi Serge Diagbouga
Potiandi Serge Diagbouga
ADArthur Diakourga Djibougou
Arthur Diakourga Djibougou
DGDanielle Guy
Danielle Guy
RBRobert Bagnall
Robert Bagnall
FRFanette Ravel
Fanette Ravel
Background: Dengue is a re-emerging infectious disease that poses substantial challenges to healthcare systems in endemic regions, such as West Africa. Owing to its nonspecific and overlapping clinical symptoms – including fever, rash, headache, joint pains, nausea, vomiting – many cases go unrecognized or are misdiagnosed. Consequently, patients are often inappropriately treated with antimalarial or antibiotic therapies. Such mismanagement not only affects patient outcomes but also contributes to the development of antimicrobial and antimalarial drug resistance within these populations. This literature review aimed to describe the patterns and impact of dengue diagnosis in West Africa. Methods: A comprehensive electronic database search of MEDLINE and Embase was conducted using keywords related to dengue, chikungunya, acute febrile illness, diagnostic strategies, and clinical management. Additional manual searches was performed through Google Scholar and relevant conference proceedings. Eligible studies included observational, real-world evidence, or interventional research conducted in West Africa involving adult patients diagnosed with dengue or chikungunya. Inclusion criteria required studies to report on diagnostic approaches and/or clinical management strategies. Due to the limited availability of data on chikungunya, this review focused exclusively on dengue. Results: Ten studies from Burkina Faso, Ivory Coast, Senegal, and Nigeria were included in this review. Rapid serologic testing (DENGUE NS1, IgG, IgM) was the most frequently used diagnostic tools, used in 60% of the studies. Clinical management of dengue primarily involved the administration of antipyretics, fluid therapy, and blood transfusions when necessary. In five studies, antimalarial treatments were systematically prescribed despite negative malaria results. Additionally, two studies reported the use of antibiotics without confirmed bacterial infection or supporting biological diagnosis, indicating inappropriate antibiotic use. Conclusions: Evidence on dengue diagnosis and related clinical management in West Africa remains limited. The available data indicate a widespread underuse of diagnosis tools and frequent misuse of antimalarial and antibiotic therapies in the management of dengue. Future studies should prioritize evaluating the impact of accurate differential diagnosis between dengue and malaria on patient care, particularly regarding the inappropriate use of antibiotics and antimalarials. Moreover, integrating routine diagnostic testing into standard clinical practice, as recommended by health authorities, could significantly improve current management. This would enable clinicians to more accurately diagnose dengue, malaria, other febrile illnesses, and potential co-infections, ultimately reducing the misuse of antimicrobial treatments.

11 June 2025 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDPotiandi Serge Diagbouga
Potiandi Serge Diagbouga
DDDiakourga Arthur DJIBOUGOU
Diakourga Arthur DJIBOUGOU
CPCamille Pease
Camille Pease
AAAriana Alcaide
Ariana Alcaide
ABAudrey Berthoux
Audrey Berthoux
MGMaria Laura Gennaro
Maria Laura Gennaro
This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with Mycobacterium tuberculosis complex (latent infection and disease). The study was multi-center and performed between 2 October 2019 and 4 February 2020. Participants were divided into tuberculosis (TB) disease, high-risk, and low-risk populations. The confirmed TB disease population included 104 patients. The high-risk population included 162 individuals with flagged risk factors on a questionnaire but without objective clinical confirmation of TB. The low-risk population included 117 healthy blood donors from the French National Blood Bank. Positive and negative percent agreement (PPA and NPA) were determined between the VIDAS TB-IGRA and QFT-Plus. In the TB disease population, sensitivity was measured against bacterial culture and PCR. The VIDAS TB-IGRA produced fewer indeterminate results than the QFT-Plus (1/104 vs 23/104) in the TB disease population and exhibited a sensitivity of 95.0% against bacterial culture. Furthermore, a 98.2% PPA was obtained in comparison to QFT-Plus. In the low-risk population, the VIDAS TB-IGRA demonstrated high specificity (94.9%) and a strong NPA (98.2%) compared to QFT-Plus. In the high-risk population, the VIDAS TB-IGRA exhibited a strong PPA (94.4%) with the QFT-Plus. A lower NPA was observed (85.2%) compared to QFT-Plus, which may be due to a higher sensitivity demonstrated in the TB disease population. The fully automated VIDAS TB-IGRA is a promising aid in the diagnosis of individuals infected with Mycobacterium tuberculosis (latent infection and active disease). It exhibits higher sensitivity while maintaining specificity and produces fewer indeterminate interpretations than QFT-Plus. Its easy-to-use, single-patient format may lead to increased TB testing to aid in the adequate diagnosis and management of the disease. IMPORTANCE: This study presents a comprehensive evaluation of the VIDAS TB-IGRA diagnostic test. This test is compared with the established QuantiFERON-TB Gold Plus to assess its effectiveness in diagnosing both latent and active tuberculosis (TB) infections. The study highlights the VIDAS TB-IGRA’s higher sensitivity, fewer indeterminate results, and robust performance across different patient populations, including those with confirmed TB disease, high-risk, and low-risk groups. The findings suggest that the VIDAS TB-IGRA could enhance TB diagnosis and management, offering a fully automated, easy-to-use solution that reduces human error and result variability.

5 May 2026 in Public Health Challenges
Verified
Journal Article
Open access
MSMadi Savadogo
Madi Savadogo
MSMalik Orou Seko
Malik Orou Seko
ICInoussa Conombo
Inoussa Conombo
GLGuesrim Lallogo
Guesrim Lallogo
SDSerge Diagbouga
Serge Diagbouga
RARianatou Bada Alambedji
Rianatou Bada Alambedji
Background: In low‐ and middle‐income countries, meat consumption is often associated with health risks due to limited awareness of zoonotic disease transmission. Burkina Faso is not exempt from these public health threats. This study aimed to assess knowledge and practices related to meat‐borne zoonotic risks among meat consumers in Burkina Faso. Methods: A cross‐sectional descriptive and analytical survey was conducted from August to November 2022, including 849 participants. Data were collected using a structured questionnaire administered through face‐to‐face interviews. Scores were attributed to assess levels of knowledge and practices regarding zoonotic risks associated with meat handling and consumption. Statistical analysis was performed using descriptive statistics and chi‐square and Fisher's exact tests. Results: According to findings, although 90.22% acknowledged that meat could transmit zoonotic diseases to humans, only 31.22% could name at least one zoonotic disease. Poor hygiene in meat sale outlets was reported by 50.77% of respondents. Good practices, such as proper meat storage, were inconsistently reported, as 66.90% reportedly stored meat exposed to open air, and 46.29% used the same utensils for meat preparation and meal service in households. Overall, level of education, professional occupation, religion and position held in the household were significantly associated with both knowledge and practices ( p < 0.05), and participants having better knowledge were more likely to adopt safer practices ( p < 0.05). Conclusion: Despite a general awareness of meat‐related health risks, including zoonotic diseases, knowledge gaps and unsafe practices remain prevalent among consumers. Reducing meat‐borne zoonotic diseases requires shifting from general awareness to actionable, behaviour‐oriented interventions. By combining community education, improved market hygiene and multi‐sectoral collaboration, public health authorities can substantially reduce preventable exposure to zoonotic pathogens while preserving the nutritional benefits of meat consumption.